Archive: 27/10/2014
Study may explain why targeted drug doesn't benefit patients with early-stage lung cancer
The drug erlotinib is highly effective in treating advanced-stage lung cancer patients whose tumors have a particular gene change, but when the same drug is used for patients with early-stage tumors with the same gene change, ...
Oct 27, 2014